期刊文献+

替米沙坦联用卡维地络治疗舒张性心衰的研究 被引量:1

Research of Diastolic Dysfunction Heart Failure Treated with Carvedilo and Telmisartan
原文传递
导出
摘要 目的探讨替米沙坦联用卡维地络对左室舒张功能不全的治疗价值。方法34例左室舒张功能不全患者作为观察组给予替米沙坦与卡维地络口服;38例作为对照组口服钙拮抗剂,分别于治疗前治疗后6个月记录舒张早期峰值血流速度(EV)、舒张晚期峰值血流速度(AV)、E/A、E峰减速时间(EDT)、等容舒张时间(IRT)。结果观察组的左室舒张功能较对照组改善明显(P<0.05~0.01)。结论替米沙坦与卡维地络联用能有效改善患者左室舒张功能。 Objective To explore the therapeutic value of carvedilo and trmisartan in left ventricular diastolic dysfunction (LVDD). Methods A total of 34 patients with left ventricular diastolic dysfunction ( LVDD ) were treated with carvedilo and trmisartan( observation group) ;38 LVDD patients were treated with calcium antagonist( control group). The blood pressure ,E velocity ,A velocity ,E/A ,E deceleration time(EDT) ,and isovolumetric relaxation time(IRT) were recorded before therapy and after six months. Results The left ventricular function in observation group ameliorated more than the control group( P 〈 0.05 ). Conclusion Treatment with carvedilo and telmisartan can effectively improve the left ventricular diastolic function.
出处 《中华全科医学》 2009年第9期943-944,共2页 Chinese Journal of General Practice
关键词 替米沙坦 卡维地络 左室舒张功能不全 Telmisartan Carvedilo Left ventricular diastolic function
  • 相关文献

参考文献1

  • 1沈泽宁.左室舒张功能不全的治疗:血管紧张素Ⅱ受体拮抗剂有作用吗[J]国外医学心血管疾病分册,2001(03).

同被引文献10

  • 1Collins A J, Li S, Gilbertson DT, et al. Chronic kidney disease and car- diovascular disease in the Medicare population[ J]. Kidney Int Suppl, 2003,11(87) :24-31.
  • 2Sarnak M J, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the Ameriean Heart Association Councils on Kidney in Cardiovascular Dis- ease,High Blood Pressure Research Clinical Cardiology and Epidemi- ology and Prevention [ J]. Circulation ,2003,108 ( 17 ) :2154-2169.
  • 3Ryekwaert F, Colson PH. Hypovolaemia-induced vasodilatation during angiotensin AT1 receptor blockade:rele of the AT2 receptor[ J]. Phar- macol Res,2005,51 ( 1 ) :37-40.
  • 4Inagaki K, Lwanaga Y, Sarai N, et al. Tissue angiotensin II during pro- gression or ventrlcular hypertrophy to heart failure in hypertensive rats; diferential effects on PKC epsilon and PKC beta[ J ]. J Mol Cell Cardi- ol,2002,34 ( 10 ) : 1377 -1385.
  • 5Stergiou GS, Makris T,Papavasiliou M, et al. Comparison of antihyper- tensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic inpatients with hypertension not controlled by angiotensin receptor blocker monotherapy [ J ]. J Hypertens, 2005,23 (4) :883-889.
  • 6Fanabiki K, Onishi K, Dohi K, et al. Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventficular stiffness in dogs with heart failure[J]. Am J Physiol Heart Circ Physi- ol,2004,287 ( 6 ) :2487-2492.
  • 7陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 8宋洁,李辉,陈会民.左卡尼汀在维持性血液透析患者中的临床应用[J].临床误诊误治,2010,23(1):85-87. 被引量:19
  • 9李庆辉,杨天伦,谭碧峰,周环,周波.替米沙坦对高血压患者左室肥厚及C反应蛋白的影响[J].中华全科医学,2010,8(5):554-556. 被引量:6
  • 10王维平,张玉强,梅长林.维持性血液透析患者微炎症与心室结构和功能及预后的相关研究[J].临床荟萃,2011,26(1):1-5. 被引量:7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部